leucopyrokinin: myotropic neuropeptide from Madeira cockroach Leucophaea maderae
ID Source | ID |
---|---|
PubMed CID | 175962 |
MeSH ID | M0141939 |
Synonym |
---|
leucopyrokinin |
(2s)-n-[(2s,3r)-1-[[(2s)-1-[[(2s)-1-[[(2s,3r)-1-[(2s)-2-[[(2s)-1-[[(2s)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hy |
104052-00-8 |
pglu-thr-ser-phe-thr-pro-arg-leu-nh2 |
DTXSID60146231 |
glp-thr-ser-phe-thr-pro-arg-leu-amide |
(s)-n-((s)-1-(((s)-1-amino-4-methyl-1-oxopentan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)-1-(((s)-5-oxopyrrolidine-2-carbonyl)-l-threonyl-l-seryl-l-phenylalanyl-l-threonyl)pyrrolidine-2-carboxamide |
Excerpt | Relevance | Reference |
---|---|---|
" The dose-response curves of myotropic and non-myotropic factors indicate that (i) proctolin, L-glutamate, octopamine, leucokinin-VI, leucopyrokinin, ecdysone and 20-hydroxy-ecdysone, or equivalent structures, might be involved in Galleria mellonella oviposition control, and (ii) that only the novel wax moth neuropeptide has the ability to trigger egg laying in that insect." | ( Separation of oviposition-stimulating peptides and myotropic factors from head extracts of Galleria mellonella L.: comparative effects of myotropic and non-myotropic factors on egg laying. Abdoun, K; Baudry-Partiaoglou, N; Cohen, P; Mesnier-Sabin, M; Nicolas, P, 1995) | 0.49 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.41) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |